Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000462873 | SCV000564007 | pathogenic | Lynch syndrome | 2016-09-05 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 2-9 of the PMS2 gene. This creates a premature translational stop signal and is expected to result in an absent or disrupted protein product. Gross deletions and loss-of-function variants in PMS2 are known to be pathogenic. This particular variant has been reported in an individual who underwent genetic testing for PMS2-related hereditary cancer (PMID: 26320870). For these reasons, this variant has been classified as Pathogenic. |